Skip to main content

ALL ABOUT MS Treatment (Part 9)

By
ALL ABOUT MS  Treatment (Part 9)

Glatiramer acetate (Copaxone)

This drug has similar effects and indications as interferon beta but a slightly different mechanism of action. It is applied at a dose of 20 mg, daily, subcutaneously. Side effects are also somewhat different, and include skin changes at the drug site and transient and short-term feeling of tightness in the chest with heart palpitations and a sense of lack of air.

Natalizumab (Tysabri)

This medicine is administered intravenously once a month. It works by preventing the immune system's entry into the brain and thus reducing the inflammatory (inflammatory) effect of immune cells on the nerve cells. Clinical trials have shown that natalizumab significantly reduces the incidence of attacks in the relapse form of MS, but in three patients it has caused a rare, but often fatal, brain disease. After this, the drug was withdrawn from the market, but in 2006 it was returned because of its positive effects on patients with MS. Now, the use of natalizumab is advised under strictly controlled conditions, and only in patients who do not respond positively to any other therapy.

Mitoxantrone (Novantrone)

Mitoxantron is a cytostatic (used in chemotherapy of many types of cancers), which is used in small doses to treat aggressive forms of relapse-remotent form of MS and certain forms of progressive form of MS. It is administered intravenously, every three months. Since mitoxantrone can cause serious side effects after prolonged use, such as heart failure, does not apply for more than two to three years.

Some doctors prescribe some other chemotherapeutic drugs, such as cyclofosfamide (Cytoxan), in the event of a serious, rapidly progressing disease. However, this drug has not been approved by the World Drug Treatment Agency for MS.

Plasmafereza


Plasmafereza is a method that successfully treats autoimmune diseases. However, it is not yet clear whether its use results in short-term or long-term results in MS treatment, and its use is still contested. Plasmapheresis can help restore neurological functions in patients with sudden severe attacks that do not respond to high-dose steroids.
Labels:

Comments

Post a Comment

Popular posts from this blog

My FEELING, My train of THOUGHT (Part 1)

By
My FEELING, My train of THOUGHT Inspired by thoughts, I am created this my short text, which is engraved in my mind!   Certainly, things like this in  future time will be a lot more!  These short texts best describe our feelings, so read carefully and with .... Just READ The direction of the eye So wrong Avoiding the soul So missing I'm not asking Our existence Just asking Why am I in a war with my hands? Why am I in a war with my feet? Why am I in the war with me? And after all, I'm still going I'm not showing I do not share I do not need it What you have to give, GIVE!
1 comment
Read more

Psychosocial counseling is mandatory

By
Psychosocial counseling is mandatory People with MS are more prone to stress than other people. With everyday stresses of modern life, MS patients are still threatened by the diagnosis, which only falls into acute stress. As MS is an unpredictable disease, the uncertainty and anticipation of the next aggravation is a particular source of stress. Multiple sclerosis brings with it a change of image about oneself, relationships with family, friends, colleagues. In addressing these problems, the role of psychosocial support and assistance is invaluable. In people living with MS, the problems of psychological nature are more often related to the personality of the diseased, the reaction to illness, and the way of adjusting and reorganizing oneself according to the change that has occurred and which the disease inevitably carries with it, rather than being associated with the illness itself cause of the problem. MS sufferers face loss of health and this loss causes a very stron
Post a Comment
Read more

ALL ABOUT MS (Part 2)

By
Types and course of the disease The course of the disease is different and difficult to predict in each person, but over time, as the MS shows certain regularities when the disease is monitored over a longer period of time, most patients can be classified into one of four MS forms. When determining MS forms, knowledge of the previous course of the disease is used to try to predict a further course of the disease. MS forms are: relapse-remitent, secondary progressive, primarily progressive and progressive-relapse form. Relapse-remitent form In 85% to 90% of diseased illnesses begin as a relapse-remitent form. In these patients, unpredictable seizures (so called relapse, exacerbations, mosses, and swabs) are observed, followed by periods when the disease recedes (remission) and in which the patient's condition returns to what was before the attack, and may also be left behind damage. When the patient's condition always returns to what was before the attack, it is usu
Post a Comment
Read more